SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Debt Repayment

Cash used to repay borrowings during the period.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Debt Repayment · Q1 FY2026 · quarter ended Mar 2026

Debt repayment of $0 in Q1 FY2026

Q1 FY2026 debt repayment was $0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Debt Repayment past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Debt Repayment history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
—

Debt Repayment vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so debt repayment is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Debt Repayment for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$540.88M USD+1001.7%—4.9%
BLCOBausch + Lomb CorporationLTM Jun 2026$141.75M USD-51.5%-53.4%2.7%
GKOSGlaukos CorporationLTM Jun 2026$526K USD+131.1%+28.6%0.1%
OCSOculis Holding AGLTM Mar 2026CHF 387K CHF+22.1%+32.9%76.8%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$99K USD-29.3%—1.3%
RXSTRxSight, Inc.LTM Mar 2026$20K USD-57.4%-40.1%0.0%
SGPSpyGlass Pharma, Inc. Common StockFY2025$0 USD———
OCULOcular Therapeutix, Inc.LTM Mar 2026$0 USD——0.0%
STAASTAAR Surgical CompanyLTM Apr 2026$0 USD+100.0%-30.7%0.0%
SGHTSight Sciences, Inc.LTM Mar 2026$0 USD-100.0%—0.0%
Peer median (excluding SGP) —-3.6%-30.7%0.1%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.